Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin
- PMID: 9458273
Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin
Abstract
Acylation stimulating protein (ASP) acts upon adipose tissue to stimulate triglyceride synthesis and glucose transport. The aim of the present study was to produce recombinant ASP and to measure its bioactivity. The cDNA region of the parent complement C3 sequence coding for ASP (C3adesArg) was cloned and expressed in E. coli. Bioactivity of the purified recombinant material was tested by determining its effect on triglyceride synthesis, glucose transport, and competition binding assays. In standard assays, concentrations of 5.5 microM recombinant ASP (rASP) stimulated triglyceride synthesis comparably to plasma ASP (pASP): 228% versus 237%, respectively, in 3T3 preadipocytes and 568% versus 440% in human differentiated adipocytes. rASP also increased glucose transport in L6 myocytes (163% at 10 microm rASP) and in human differentiated adipocytes (334% rASP vs. 329% pASP at 5 microM). rASP competitively displaced radiolabeled plasma ASP from high affinity association with the cell surface in both human differentiated adipocytes and 3T3 preadipocyte fibroblasts. Furthermore, immunoprecipitation of rASP and pASP with a specific monoclonal antibody abolished stimulation of cellular triglyceride synthesis. Lastly, we contrasted the structure:function activities of the arginated (C3a) and desarginated (ASP) proteins. The lipogenic activity and the anaphylatoxic activity result from distinct structural domains of the polypeptides. Thus rASP retains full biologic ASP activity and may provide a tool to study structure-function relationships in this physiologic system.
Similar articles
-
Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):41-8. Biochem J. 1999. PMID: 10432298 Free PMC article.
-
Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: a critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation.Mol Immunol. 2009 Oct;46(16):3207-17. doi: 10.1016/j.molimm.2009.08.013. Epub 2009 Sep 19. Mol Immunol. 2009. PMID: 19767107
-
Adipsin/acylation stimulating protein system in human adipocytes: regulation of triacylglycerol synthesis.Biochemistry. 1994 Aug 16;33(32):9489-95. doi: 10.1021/bi00198a014. Biochemistry. 1994. PMID: 8068623
-
A critical evaluation of the putative role of C3adesArg (ASP) in lipid metabolism and hyperapobetalipoproteinemia.Mol Immunol. 1999 Sep-Oct;36(13-14):869-76. doi: 10.1016/s0161-5890(99)00108-x. Mol Immunol. 1999. PMID: 10698341 Review.
-
Acylation stimulating protein (ASP), an adipocyte autocrine: new directions.Semin Cell Dev Biol. 1999 Feb;10(1):31-41. doi: 10.1006/scdb.1998.0272. Semin Cell Dev Biol. 1999. PMID: 10355026 Review.
Cited by
-
The Controversial C5a Receptor C5aR2: Its Role in Health and Disease.J Immunol Res. 2017;2017:8193932. doi: 10.1155/2017/8193932. Epub 2017 Jun 15. J Immunol Res. 2017. PMID: 28706957 Free PMC article. Review.
-
Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity.Biochem J. 1999 Aug 15;342 ( Pt 1)(Pt 1):41-8. Biochem J. 1999. PMID: 10432298 Free PMC article.
-
Recombinant acylation stimulating protein administration to C3-/- mice increases insulin resistance via adipocyte inflammatory mechanisms.PLoS One. 2012;7(10):e46883. doi: 10.1371/journal.pone.0046883. Epub 2012 Oct 8. PLoS One. 2012. PMID: 23056509 Free PMC article.
-
Nicotinic α7 receptor inhibits the acylation stimulating protein‑induced production of monocyte chemoattractant protein‑1 and keratinocyte‑derived chemokine in adipocytes by modulating the p38 kinase and nuclear factor‑κB signaling pathways.Mol Med Rep. 2016 Oct;14(4):2959-66. doi: 10.3892/mmr.2016.5630. Epub 2016 Aug 12. Mol Med Rep. 2016. PMID: 27572255 Free PMC article.
-
Relationship of C5L2 receptor to skeletal muscle substrate utilization.PLoS One. 2013;8(2):e57494. doi: 10.1371/journal.pone.0057494. Epub 2013 Feb 27. PLoS One. 2013. PMID: 23460866 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous